Back to search

Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil.

Data up to Jan 2025

Published1996
Citations240
References10

Total Citations Per Year

Abstract

Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer… (1996) – Journal of Clinical Oncology | Metascience Observatory Explorer